No time for a #bluetorial today, but happy to share a new preprint from the lab. In this paper we used gene saturation and cancer-mutation-focused base editing screens to unveil genetic drivers of resistance to multiple KRAS inhibitors. www.biorxiv.org/content/10.1...
Genetic mechanisms of resistance to targeted KRAS inhibition
KRAS mutations are among the most prevalent oncogenic drivers in non-small cell lung cancer (NSCLC), yet the mechanisms of therapeutic resistance to KRAS inhibitors in these cancers remains poorly und...
biorxiv.org